Researchers Offer Comprehensive Look at Rosacea Treatment Options
February 12th 2022Affecting up to 1 in 10 people worldwide, rosacea has a complex pathophysiology that remains inadequately understood, and research has hinted at multiple inflammatory and immune mediated processes underlying the condition.
Read More
Researchers Determine What Patients, Caregivers Deem Meaningful Change in SMA Motor Function
February 12th 2022Through the use of patient testimonials as well as analysis of data from a study of patients with spinal muscular atrophy (SMA), researchers were able to describe patient-centered “meaningful outcomes” in the 32-item Motor Function Measure.
Read More
Early Response to Biologics Linked With Stable Long-term Efficacy in Psoriasis
February 12th 2022More patients with moderate-to-severe psoriasis were found to be early responders to ixekizumab vs ustekinumab; all those who achieved early response were associated with stable skin clearance long-term.
Read More
Exercise Interventions Benefit Patients With Asthma, Review Shows
February 12th 2022While it is known that the promotion of physical activity can improve asthma symptoms and quality of life—and is even recommended in asthma guidelines— such behavior change is often difficult due to lack of funding or reimbursement for pulmonary rehabilitation or for other reasons.
Read More
More Info Needed to Establish Utility of MRD, SFLC Levels as Biomarkers in MM
February 12th 2022This new study synthesized data from 5 clinical trials at the University of California, San Francisco, to evaluate the utility of minimal residual disease (MRD) and serum-free light chain (SFLC) levels in predicting progression-free survival among patients with multiple myeloma (MM) receiving chimeric antigen receptor T-cell therapies.
Read More
IO-TKI Combinations Have Potential as Preferred First-line mRCC Therapy
February 12th 2022Metastatic renal cell carcinoma (mRCC) has seen increased treatment options in recent years, including immunotherapy (IO) combinations paired with tyrosine kinase inhibitors (TKI). A meta-analysis of phase 3 trials aimed to compare and rank available first-line treatments.
Read More
Switching to Dry Powder Asthma Inhaler Better for Climate Change, Researchers Say
February 11th 2022Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered dose inhaler containing hydrofluorocarbon propellant.
Read More
Dr Robert Gabbay on the Intersection of COVID-19 and Diabetes
February 11th 2022Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, shares his thoughts on long COVID-19 among those with type 2 diabetes and the rise of new-onset cases of type 1 diabetes throughout the pandemic.
Watch
Dr Ted Mikuls on Gout Study: BMI Was Independent of Amputation Rate
February 11th 2022Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, explains how lower extremity amputation among US veterans with gout was independent of body mass index (BMI) and other risk factors.
Watch
VA Study: Patients Switching to Biosimilar Infliximab More Likely to Stop Treatment
February 11th 2022Physician and patient resistance to switching from an innovator or reference product to a biosimilar—or from one biosimilar to another—constitutes one of the major barriers to biosimilar adoption, despite the cost savings that can be achieved.
Read More
Improving Models to Boost Prediction of CVD Issues in Patients With CKD
February 10th 2022Adding risk factors specific to patients with chronic kidney disease (CKD) to risk prediction models for cardiovascular disease (CVD) could improve risk prediction capabilities for a population of patients often subject to invasive diagnostic procedures, investigators concluded.
Read More
Dr Kenneth Cohen on Education, Tools to Reduce Low-Value Care
February 10th 2022Kenneth Cohen, MD, FACP, executive director of clinical research at UnitedHealth Group Research and Development and senior national medical director at OptumCare, discusses evidence-based education and other tools to address low-value care.
Watch